Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Aemetis Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Aemetis şirketinin toplam hissedar öz sermayesi $-249.0M ve toplam borcu $429.5M olup, bu da borç-öz sermaye oranını -172.5% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $232.1M ve $481.0M dir.

Anahtar bilgiler

-172.5%

Borç/özkaynak oranı

US$429.53m

Borç

Faiz karşılama oranı	n/a
Nakit	US$234.00k
Eşitlik	-US$248.95m
Toplam yükümlülükler	US$481.04m
Toplam varlıklar	US$232.09m

Son finansal sağlık güncellemeleri

Recent updates

Aemetis: Low Cash Reserves With An Uphill Battle To Secure More Financing

Sep 17

Take Care Before Jumping Onto Aemetis, Inc. (NASDAQ:AMTX) Even Though It's 25% Cheaper

Aug 08

Cautious Investors Not Rewarding Aemetis, Inc.'s (NASDAQ:AMTX) Performance Completely

Dec 20

Need To Know: Analysts Are Much More Bullish On Aemetis, Inc. (NASDAQ:AMTX) Revenues

May 21

Investors Aren't Entirely Convinced By Aemetis, Inc.'s (NASDAQ:AMTX) Revenues

Apr 18

Aemetis wins $7B worth of fuel supply contracts

Sep 07

Aemetis GAAP EPS of -$0.01 beats by $0.35, revenue of $65.9M beats by $6.58M

Aug 04

Aemetis: Waiting For Signs Of Profitability

May 04

Aemetis inks $200M deal for low carbon biofuels

Jun 14

Aemetis nabs second U.S. patent for using waste forest wood to produce high value biofuels

May 26

Aemetis, Inc. (NASDAQ:AMTX): Are Analysts Optimistic?

May 10

Aemetis soars 22% on opening bid proposal process for $2B offtake agreement for “Carbon Zero” biofuels

Feb 01

When Will Aemetis, Inc. (NASDAQ:AMTX) Breakeven?

Jan 25

Aemetis stock higher on entering EV market through 20% stake in Nevo Motors

Dec 22

The Aemetis (NASDAQ:AMTX) Share Price Is Up 318% And Shareholders Are Delighted

Dec 04

Aemetis subsidiary receives $7.8M in CDFA Grants

Nov 20

Aemetis EPS misses by $0.54, misses on revenue

Nov 12

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: AMTX negatif hissedar özkaynağı var; bu, kısa vadeli varlıkların kısa vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Uzun Vadeli Yükümlülükler: AMTX şirketinin negatif özkaynağı bulunmaktadır; bu, kısa vadeli varlıkların uzun vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: AMTX negatif hissedar özkaynağı var ki bu yüksek borç seviyesinden daha ciddi bir durumdur.

Borcun Azaltılması: AMTX 'in negatif özkaynağı var, dolayısıyla borcunun zaman içinde azalıp azalmadığını kontrol etmemize gerek yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: AMTX şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: AMTX un, serbest nakit akışı her yıl % 24.3 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Aemetis Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Aemetis, Inc. announced delayed annual 10-K filing

Aemetis, Inc. announced delayed 10-Q filing

Recent updates

Aemetis: Low Cash Reserves With An Uphill Battle To Secure More Financing

Take Care Before Jumping Onto Aemetis, Inc. (NASDAQ:AMTX) Even Though It's 25% Cheaper

Aemetis, Inc. to Report Q2, 2024 Results on Aug 01, 2024

Investors Give Aemetis, Inc. (NASDAQ:AMTX) Shares A 25% Hiding

Aemetis: Getting Ready For Breakout Growth

Aemetis, Inc. to Report Q1, 2024 Results on May 09, 2024

Aemetis, Inc., Annual General Meeting, May 29, 2024

Aemetis, Inc. announced delayed annual 10-K filing

Consensus EPS estimates fall by 92%

Forecast breakeven date pushed back to 2026

Full year 2023 earnings released: US$1.22 loss per share (vs US$3.12 loss in FY 2022)

Aemetis, Inc. to Report Q4, 2023 Results on Mar 07, 2024

Aemetis: Counting On The Potential

Price target increased by 9.3% to US$12.42

Price target increased by 8.8% to US$12.67

Cautious Investors Not Rewarding Aemetis, Inc.'s (NASDAQ:AMTX) Performance Completely

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Aemetis, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Independent Director recently sold US$85k worth of stock

Aemetis, Inc. Appoints J. Michael Rockett as Executive Vice President, General Counsel and Corporate Secretary

Price target increased by 10% to US$13.33

Aemetis, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Aemetis, Inc. Resumes Operations at 65 MGY California Biofuel Plant After Completing Extensive Maintenance and Upgrades

Need To Know: Analysts Are Much More Bullish On Aemetis, Inc. (NASDAQ:AMTX) Revenues

Consensus revenue estimates increase by 12%

Aemetis, Inc.'s RNG Production Facility Receives EPA Approval for D3 RNG Generation

First quarter 2023 earnings released: US$0.72 loss per share (vs US$0.54 loss in 1Q 2022)

Price target decreased by 16% to US$10.14

Investors Aren't Entirely Convinced By Aemetis, Inc.'s (NASDAQ:AMTX) Revenues

Forecast breakeven date pushed back to 2025

Consensus EPS estimates fall by 32%

Price target decreased by 8.7% to US$12.04

Consensus EPS estimates fall by 79%

Full year 2022 earnings released: US$3.12 loss per share (vs US$1.54 loss in FY 2021)

Price target decreased by 14% to US$13.18

Aemetis Biogas Accepts Digesters, 36 mile Pipeline and RNG Upgrade Facility as Placed In Service and Fully Operational

Price target decreased to US$15.71

Price target increased to US$21.50

Third quarter 2022 earnings released: US$2.01 loss per share (vs US$0.55 loss in 3Q 2021)

American Power Group and Aemetis Biogas Conduct Multiple California Demonstrations of American Power Group's V6000 Low-Carbon Dual Fuel Solution for Class 8 Trucks

Aemetis wins $7B worth of fuel supply contracts

Consensus forecasts updated

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Aemetis GAAP EPS of -$0.01 beats by $0.35, revenue of $65.9M beats by $6.58M

Aemetis, Inc. announced delayed 10-Q filing

Aemetis: Waiting For Signs Of Profitability

Aemetis, Inc., Annual General Meeting, May 26, 2022

Forecast breakeven date pushed back to 2024

Consensus estimates of losses per share improve by 15%

Independent Director recently sold US$424k worth of stock

Independent Director notifies of intention to sell stock

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Lead Independent Director exercised options to buy US$1.5m worth of stock.

Lead Independent Director exercised options to buy US$1.5m worth of stock.

Third quarter 2021 earnings released: US$0.55 loss per share (vs US$0.59 loss in 3Q 2020)

Lead Independent Director exercised options and sold US$372k worth of stock

Executive VP & COO recently sold US$120k worth of stock

Price target decreased to US$28.33

Consensus forecasts updated

Second quarter 2021 earnings released: US$0.34 loss per share (vs US$0.11 profit in 2Q 2020)

Price target decreased to US$31.17

Executive VP & MD notifies of intention to sell stock

Aemetis inks $200M deal for low carbon biofuels

Aemetis Present the Aemetis Corporate Presentation, Serve on the “Future of Energy” Panel

Independent Director notifies of intention to sell stock

Aemetis nabs second U.S. patent for using waste forest wood to produce high value biofuels

Aemetis Notified of US Forest Service Grant for Patented Process Enabling Use of Waste Wood for the ‘Carbon Zero’ Jet/Diesel Plant

Forecast breakeven moved forward to 2022

First quarter 2021 earnings released: US$0.69 loss per share (vs US$0.58 loss in 1Q 2020)

Aemetis, Inc. (NASDAQ:AMTX): Are Analysts Optimistic?

Aemetis Achieves Major Project Milestone by Receiving Authority to Construct Permits for ‘Carbon Zero’ Renewable Fuels Plant

Executive VP & COO notifies of intention to sell stock

Consensus EPS estimates fall to -US$1.85